Antibiotics are used in the treatment of bacterial infections. They kill and inhibit the growth of bacteria, allowing the infection to subside and the patient to recover. However, during the last few years, increasing numbers of bacteria have developed so-called antibiotic resistance, which means they are resistant to the effects of antibiotics. Over time, these types of medication become ineffective and multi-resistant bacteria become even more widespread as a result.
Scientists have now discovered that there is a point in the production process of the proteins at which it can be regulated by bacteria. This could be used as a starting point for the development of new antibiotics and help overcome resistance to antibiotics.
The discovery published in the scientific journal Nature Communications, could be a completely new starting point in developing antibiotics. Researchers have discovered that the early phase of ribonucleic acid (RNA) production is the key to controlling the regulation of bacterial gene expression.
In bacteria, the RNA is produced using a large protein complex called RNA polymerase (RNAP). The RNAP reads the DNA sequence and builds a copy of the RNA by joining nucleotides together - the fundamental building blocks of RNA - during a process called transcription. Since this production of RNA is fundamental for the survival of the bacteria, it has already been the subject of intensive research and used as the starting point for developing antibiotics, for example for the treatment of tuberculosis. However, it remained unclear how the production of RNA is also regulated at the stage of early transcription when RNAP has just begun to join together the first few RNA building blocks. This was the subject of the research carried out by the team of scientists.
The researchers used high-end fluorescence microscopy, which allowed them to monitor individual RNAP molecules as they started to produce RNA. They discovered that the initial RNA synthesis is strongly regulated - a certain sequence of DNA forces the RNAP to pause after adding 6 nucleotides (ITC6).
The paused ITC6 acts as a checkpoint that directs RNAP to one of three competing pathways: productive transcription, abortive RNA release, or a new unscrunching/scrunching pathway. The cyclic unscrunching/scrunching of the promoter generates a long-lived, RNA-bound paused state; the abortive RNA release and DNA unscrunching are thus not as tightly linked as previously thought.
This discovery completely changes our previous understanding of initial RNA synthesis in bacteria. 'The fact that the RNAP can be simultaneously bound to the DNA and the short piece of RNA for a longer period of time was very surprising, as it contradicts current knowledge,' says the author. The discovery of this new checkpoint in gene expression could be used for the development of new antibiotics. 'For example, it may be possible to develop medication that locks the RNAP in the paused state, thus killing the bacteria that cause illnesses,' says the author.
A new regulatory checkpoint in bacterial gene expression
- 332 views